NY QETC Capital Tax Credit

NY QETC Capital Tax Credit

Funds qualifying New York ventures with tax-based capital support for economic development and growth-stage expansion.

Eligibility · United States · US-NY

The New York Qualified Emerging Technology Company (QETC) Capital Tax Credit is a New York State income tax credit available to investors who make qualified investments in certified New York QETCs — early-stage technology companies operating in emerging technology and life sciences sectors. Unlike most R&D credits that reward the company conducting research, the QETC Capital Tax Credit rewards investors for deploying capital into qualifying technology companies, making it an indirect incentive that lowers the effective cost of equity investment in New York deeptech startups. Eligible companies must be certified as QETCs by the New York Department of Taxation and Finance (DTF) based on criteria including New York-based operations, product or service in an emerging technology category, and annual revenues below applicable thresholds.

The credit equals a percentage of the qualified investment made in a certified QETC during the tax year, subject to per-company and per-investor caps. Structured award values in this record range from $1,000 to $300,000 with a median near $50,000, reflecting the per-investment credit ceiling rather than a grant pool. Eligible industries include biotech, medtech, AI infrastructure, and hardware — consistent with New York's broadly defined emerging technology categories. The credit applies to investments at TRL 2–7, spanning early-stage research through validated pilot systems, indicating suitability for pre-revenue and growth-stage technology companies.

New York technology companies benefit indirectly from the QETC Capital Tax Credit by being easier to fundraise from in-state investors who receive a tax offset on their investment. To maximize this benefit, companies seeking certification should verify QETC eligibility criteria with DTF early in the fundraising process and communicate the investor-side credit availability to prospective New York-based investors as part of their pitch. The credit is non-competitive — eligibility is determined by statutory criteria, not discretionary scoring — but certification by DTF is a prerequisite that requires advance planning.